Natural products for cancer prevention associated with Nrf2–ARE pathway

Food Science and Human Wellness

Volumn 2, Issue 1, 2013, Pages 22-28

  Kou, Xianjuan ^a   Kirberger, Michael ^b   Yang, Yi ^a   Chen, Ning ^a,c  

^a WUHAN SPORTS UNIVERSITY   (China)

^b CLAYTON STATE UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Cancer prevention; Dietary phytochemicals; Natural products; Nrf2 ARE pathway; Tumorigenesis

Indexed keywords

EID: 85069004862     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2013.01.001     Document Type: Article

References (77)

1. Moolgavkar, S.H., The multistage theory of carcinogenesis and the age distribution of cancer in man. Journal of the National Cancer Institute 61:1 (1978), 49–52.
2. Jeong, W.S., Kim, I.W., Hu, R., et al. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharmaceutical Research 21:4 (2004), 661–670.
3. Keum, Y.S., Jeong, W.S., Kong, A.N., Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutation Research 555:1/2 (2004), 191–202.
4. Chen, C., Kong, A.N., Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends in Pharmacological Sciences 26:6 (2005), 318–326.
5. Zhang, D.D., Mechanistic studies of the Nrf2–Keap1 signaling pathway. Drug Metabolism Reviews 38:4 (2006), 769–789.
6. Fahey, J.W., Haristoy, X., Dolan, P.M., et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic–resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proceedings of the National Academy of Sciences of the United States of America 99:11 (2002), 7610–7615.
7. Ameyar, M., Wisniewska, M., Weitzman, J.B., A role for AP-1 in apoptosis: the case for and against. Biochimie 85:8 (2003), 747–752.
8. Shaulian, E., Karin, M., AP-1 as a regulator of cell life and death. Nature Cell Biology 4:5 (2002), E131–E136.
9. Eferl, R., Wagner, E.F., AP-1: a double-edged sword in tumorigenesis. Nature Reviews Cancer 3:11 (2003), 859–868.
10. Surh, Y.J., Kundu, J.K., Na, H.K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica 74:13 (2008), 1526–1539.
11. Lau, A., Villeneuve, N.F., Sun, Z., et al. Dual roles of Nrf2 in cancer. Pharmacological Research 58:5/6 (2008), 262–270.
12. Li, Y., Paonessa, J.D., Zhang, Y., Mechanism of chemical activation of Nrf2. PLoS ONE, 7(4), 2012, e35122.
13. Chen, X.L., Kunsch, C., Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Current Pharmaceutical Design 10:8 (2004), 879–891.
14. Lee, J.S., Surh, Y.J., Nrf2 as a novel molecular target for chemoprevention. Cancer Letters 224:2 (2005), 171–184.
15. Furukawa, M., Xiong, Y., BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Molecular and Cellular Biology 25:1 (2005), 162–171.
16. Lee, J.M., Johnson, J.A., An important role of Nrf2–ARE pathway in the cellular defense mechanism. Journal of Biochemistry and Molecular Biology 37:2 (2004), 139–143.
17. Zhao, C.R., Gao, Z.H., Qu, X.J., Nrf2–ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiology 34:5 (2010), 523–533.
18. Na, H.K., Surh, Y.J., Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Molecular Carcinogenesis 45:6 (2006), 368–380.
19. Dinkova-Kostova, A.T., Holtzclaw, W.D., Kensler, T.W., The role of Keap1 in cellular protective responses. Chemical Research in Toxicology 18:12 (2005), 1779–1791.
20. Bloom, D.A., Jaiswal, A.K., Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. Journal of Biological Chemistry 278:45 (2003), 44675–44682.
21. Yu, R., Chen, C., Mo, Y.Y., et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. Journal of Biological Chemistry 275:51 (2000), 39907–39913.
22. Kang, K.W., Choi, S.H., Kim, S.G., Peroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of phosphatidylinositol 3-kinase: the role of nitric oxide synthase in rat glutathione S-transferase A2 induction. Nitric Oxide 7:4 (2002), 244–253.
23. Cullinan, S.B., Diehl, J.A., PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. Journal of Biological Chemistry 279:19 (2004), 20108–20117.
24. Huang, H.C., Nguyen, T., Pickett, C.B., Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. Journal of Biological Chemistry 277:45 (2002), 42769–42774.
25. Numazawa, S., Ishikawa, M., Yoshida, A., et al. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. American Journal of Physiology – Cell Physiology 285:2 (2003), C334–C342.
26. Misra, P., Owuor, E.D., Li, W., et al. Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP), Stimulation of transcriptional regulation by mitogen-activated protein kinase. Journal of Biological Chemistry 277:50 (2002), 48745–48754.
27. Yu, R., Mandlekar, S., Lei, W., et al. p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. Journal of Biological Chemistry 275:4 (2000), 2322–2327.
28. Balogun, E., Hoque, M., Gong, P., et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal 371:Pt 3 (2003), 887–895.
29. Kang, K.W., Cho, M.K., Lee, C.H., et al. Activation of phosphatidylinositol 3-kinase and Akt by tert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells. Molecular Pharmacology 59:5 (2001), 1147–1156.
30. Nakaso, K., Yano, H., Fukuhara, Y., et al. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Letters 546:2/3 (2003), 181–184.
31. Pi, J., Bai, Y., Reece, J.M., et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radical Biology and Medicine 42:12 (2007), 1797–1806.
32. Talalay, P., Fahey, J.W., Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. Journal of Nutrition 131:11 Suppl. (2001), 3027S–3033S.
33. Chen, C., Kong, A.N., Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radical Biology and Medicine 36:12 (2004), 1505–1516.
34. Surh, Y.J., Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3:10 (2003), 768–780.
35. Chen, C., Yu, R., Owuor, E.D., et al. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Archives of Pharmacal Research 23:6 (2000), 605–612.
36. Andreadi, C.K., Howells, L.M., Atherfold, P.A., et al. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Molecular Pharmacology 69:3 (2006), 1033–1040.
37. Wu, C.C., Hsu, M.C., Hsieh, C.W., et al. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sciences 78:25 (2006), 2889–2897.
38. Sriram, N., Kalayarasan, S., Sudhandiran, G., Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2–Keap1 signaling. Pulmonary Pharmacology and Therapeutics 22:3 (2009), 221–236.
39. Na, H.K., Kim, E.H., Jung, J.H., et al. (−)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Archives of Biochemistry and Biophysics 476:2 (2008), 171–177.
40. Na, H.K., Surh, Y.J., Intracellular signaling network as a prime chemopreventive target of (−)-epigallocatechin gallate. Molecular Nutrition & Food Research 50:2 (2006), 152–159.
41. Yang, C.S., Lambert, J.D., Hou, Z., et al. Molecular targets for the cancer preventive activity of tea polyphenols. Molecular Carcinogenesis 45:6 (2006), 431–435.
42. Cao, Y., Cao, R., Angiogenesis inhibited by drinking tea. Nature, 398(6726), 1999, 381.
43. Jung, Y.D., Ellis, L.M., Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. International Journal of Experimental Pathology 82:6 (2001), 309–316.
44. Chen, C., Shen, G., Hebbar, V., et al. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24:8 (2003), 1369–1378.
45. Adhami, V.M., Siddiqui, I.A., Ahmad, N., et al. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Research 64:23 (2004), 8715–8722.
46. Yuan, J.H., Li, Y.Q., Yang, X.Y., Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2–UGT1A signal pathway in nude mice. Pharmacology 80:4 (2007), 269–278.
47. Hsieh, T.C., Wu, J.M., Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Experimental Cell Research 249:1 (1999), 109–115.
48. Dong, Z., Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Research 523/524 (2003), 145–150.
49. Chen, C.Y., Jang, J.H., Li, M.H., et al. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochemical and Biophysical Research Communications 331:4 (2005), 993–1000.
50. Jang, J.H., Surh, Y.J., Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutation Research 496:1/2 (2001), 181–190.
51. Jang, J.H., Surh, Y.J., Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radical Biology and Medicine 34:8 (2003), 1100–1110.
52. Liu, B.L., Zhang, X., Zhang, W., et al. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biology and Therapy 6:12 (2007), 1833–1836.
53. Kumar, A., Singh, C.K., Lavoie, H.A., et al. Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Molecular Pharmacology 80:3 (2011), 446–457.
54. Kode, A., Rajendrasozhan, S., Caito, S., et al. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. American Journal of Physiology – Lung Cellular and Molecular Physiology 294:3 (2008), L478–L488.
55. Hatcher, H., Planalp, R., Cho, J., et al. Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 65:11 (2008), 1631–1652.
56. Mandal, M.N., Patlolla, J.M., Zheng, L., et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology and Medicine 46:5 (2009), 672–679.
57. Sreejayan, Rao, M.N., Nitric oxide scavenging by curcuminoids. Journal of Pharmacy and Pharmacology 49:1 (1997), 105–107.
58. Nishinaka, T., Ichijo, Y., Ito, M., et al. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Toxicology Letters 170:3 (2007), 238–247.
59. Myzak, M.C., Dashwood, R.H., Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Letters 233:2 (2006), 208–218.
60. Zhang, Y., Talalay, P., Cho, C.G., et al. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proceedings of the National Academy of Sciences of the United States of America 89:6 (1992), 2399–2403.
61. Bacon, J.R., Williamson, G., Garner, R.C., et al. Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis 24:12 (2003), 1903–1911.
62. Basten, G.P., Bao, Y., Williamson, G., Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis 23:8 (2002), 1399–1404.
63. Jiang, Z.Q., Chen, C., Yang, B., et al. Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sciences 72:20 (2003), 2243–2253.
64. Brooks, J.D., Paton, V.G., Vidanes, G., Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiology, Biomarkers and Prevention 10:9 (2001), 949–954.
65. Munday, R., Munday, C.M., Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. Journal of Agricultural and Food Chemistry 52:7 (2004), 1867–1871.
66. Riedl, M.A., Saxon, A., Diaz-Sanchez, D., Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clinical Immunology 130:3 (2009), 244–251.
67. Gamet-Payrastre, L., Lumeau, S., Gasc, N., et al. Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anti-Cancer Drugs 9:2 (1998), 141–148.
68. Gamet-Payrastre, L., Li, P., Lumeau, S., et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Research 60:5 (2000), 1426–1433.
69. Yu, R., Lei, W., Mandlekar, S., et al. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. Journal of Biological Chemistry 274:39 (1999), 27545–27552.
70. Yang, C.S., Chhabra, S.K., Hong, J.Y., et al. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. Journal of Nutrition 131:3s (2001), 1041S–1045S.
71. Shukla, Y., Kalra, N., Cancer chemoprevention with garlic and its constituents. Cancer Letters 247:2 (2007), 167–181.
72. Herman-Antosiewicz, A., Powolny, A.A., Singh, S.V., Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacologica Sinica 28:9 (2007), 1355–1364.
73. Jeong, W.S., Jun, M., Kong, A.N., Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxidants and Redox Signalling 8:1/2 (2006), 99–106.
74. Sparnins, V.L., Barany, G., Wattenberg, L.W., Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 9:1 (1988), 131–134.
75. Lubet, R.A., Yao, R., Grubbs, C.J., et al. Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response element. Chemico-Biological Interactions 182:1 (2009), 22–28.
76. Fisher, C.D., Augustine, L.M., Maher, J.M., et al. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metabolism and Disposition: The Biological Fate of Chemicals 35:6 (2007), 995–1000.
77. Kensler, T.W., Egner, P.A., Dolan, P.M., et al. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1, 2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Research 47:16 (1987), 4271–4277.